久久久久免费_精品国产乱码久久久久久久软件_欧美一区亚洲一区_国产一区二区三区高清在线观看_欧美日在线观看_成人网av

Predictive Biosciences  
癌癥分子診斷
Predictive  Biosciences develops novel molecular diagnostic cancer assays and provides molecular pathology services for urology-based practices. Leveraging a portfolio of patented biomarkers and clinical approaches, the company has built a unique portfolio of assays for cancer management, first targeted at bladder and prostate cancer. The company is backed by leading investors, including Flybridge Capital Partners, Highland Capital Partners, Kaiser Permanente Ventures, New Enterprises Associates, Inc. (NEA) and ProQuest Investments.